Gyre Therapeutics, Inc. Operating Lease, Liability, Current
Gyre Therapeutics, Inc. (GYRE) had Operating Lease, Liability, Current of $1.39 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Current $1.39M.
- 2026-03-31: Operating Lease, Liability, Current $751.00K.
- 2025-12-31: Operating Lease, Liability, Current $1.12M; Operating Lease, Liability, Current as first filed $636.00K.
- 2025-09-30: Operating Lease, Liability, Current $626.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.39M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $751.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.12M 10-Q · filed 2026-08-07 | $636.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $626.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $622.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $805.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $713.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $694.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $659.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $210.00K 10-K · filed 2025-03-17 | |
| 2022-12-31 | $492.00K 10-K · filed 2024-03-27 | $38.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $381.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.42M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.91M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.98M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.84M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.81M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $678.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $663.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $519.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $507.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $495.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $483.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $472.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $461.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $450.00K 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |